Could patients glean stock tips?: Drug trial participants may be insider trading.

Could patients glean stock tips?: Drug trial participants may be insider trading. “Patients in clinical trials might be using information about the drug they are taking to trade illegally in pharmaceutical stocks, warns a group of doctors and bioethicists. But they have no idea how prevalent the problem might be.”


Financial Snapshot For March 2004: Looking Good

Financial Snapshot For March 2004: Looking Good “It’s been a rocky first quarter for the biotech stocks � and for the markets in general. Yet, despite investors’ nervousness � about issues as diverse as the terrorist train bombing in Madrid and the departure of Mark McClellan from the FDA � the biotech sector managed to […]


Can the world afford to reject GM foods?

Can the world afford to reject GM foods? “At a meeting in Brussels this week Dr Clive James, chair of the international service for the acquisition of agri-biotech applications (ISAAA) and a leading proponent of agricultural biotechnology for the developing world, said that global food production will need to be doubled by 2050 to meet […]